Phacilitate Advanced Therapies Europe 2026 tackled cell and gene therapy commercialization barriers as stakeholders work to ...

Samsung Biologics secures $262m manufacturing deal with European pharma as it expands Bio Campus II at Songdo to 720 kL by ...

Biopharma leaders soon will learn to partner with wearable AI systems to facilitate communication and decision-making in ...

A recent scientific report found almost 19,000 doctored images of antibodies available in the commercial market.

AI tools are reshaping drug development and manufacturing, but their effectiveness depends on robust data and human ...

Eli Lilly will acquire Merida Biosciences for up to $2.875 billion, gaining MER511, a Phase I therapy targeting ...

Large pharmaceutical firm Novartis confirmed that it is halting and investigating several clinical trial programs involving ...

Next-gen AAV manufacturing can enable scalable, affordable gene therapies through producer cell lines, process ...

As BIG Executive Summit participants reveal, biomanufacturing innovations often fail due to fragmented pathways for adoption, ...

Human-in-the-loop models could provide a credible and scalable path forward for using agentic AI in biopharma commercial ...

The organization is nurturing talent alongside NIBRT to fill the region’s many life science manufacturing jobs.

Learn how strategic CHO cell line development accelerates biologics timelines and supports clinical progression with flexible ...